1Chinese Societies of Liver Cancer and Clinical Oncology, Chinese Anti-Cancer Association; Liver Cancer Study Group, Chinese Society of Hepatology, Chinese Medical Association. Expert consensus on standardization of the management of primary liver cancer. Chin J Hepatol, 2009, 17: 403-410. (in Chinese).
2Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer, 2009, 45: 228-247.
